在癌症中代谢和表观遗传修饰之间的联系
Guangchao Wang1, Jingdong J Han1
1Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Center for Quantitative Biology (CQB), Peking University, Beijing, China.
Medical review (2021)
|September 19, 2023
概括
细胞代谢显著影响表观遗传修饰,影响基因表达和细胞功能. 癌症中的代谢重编程改变了表观遗传风景,提供了潜在的治疗点.
科学领域:
- 细胞生物学 细胞生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 癌症代谢 癌症代谢
背景情况:
- 细胞代谢和表观遗传修饰是密切相关的,影响着染色质结构和基因表达.
- 营养素的可用性会影响表观遗传的维持,这对恒常,生长和分化至关重要.
- 癌细胞表现出代谢重编程和表观遗传改变,驱动瘤的发展.
研究的目的:
- 审查代谢重编程在调节癌症表观遗传修饰中的作用.
- 突出涉及癌症相关表观遗传变化的关键代谢物.
- 探索针对癌症治疗的代谢-表观遗传交叉的潜力.
主要方法:
- 文献综述总结了有关代谢重编程和癌症表观遗传学的当前证据.
- 专注于关键代谢物及其对表观遗传修饰的影响.
- 对瘤信号驱动的代谢变化的分析.
主要成果:
- 代谢重编程通过关键代谢物水平 (SAM,乙-CoA,α-KG,2-HG,UDP-GlcNAc,乳酸盐) 改变表观遗传修饰.
- 这些代谢物动态调节癌细胞中的表观遗传场景.
- 代谢物丰度的变化是由瘤原体信号驱动的.
结论:
- 代谢重编程是癌症发展和进展的关键因素.
- 了解新陈代谢和表观遗传学之间的相互作用可以揭示癌症机制.
- 准代谢-表观遗传相互作用为新型癌症疗法提供了一个有希望的途径.
相关概念视频
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K


